• Healthcare

    In the Healthcare Services segment, attractive investment opportunities are driven by capacity expansion, consolidation amongst service providers, and value creation through service improvement in what continues to be a fragmented and inefficient market.

     

    In the Pharma and Medtech segments, we seek to identify companies that stand to benefit from trends towards enhanced consumer choice, improved information available to patients and prevention over treatment.

  • Meet the team

    Frédéric Stévenin

    Benoit Bousquié

    Hemant Kapoor

    Andreas Kumeth

    Arnaud van Tichelen

    Sébastien Veil

  • VAMED care

    VAMED care is a European leader, providing essential rehabilitation services to over 100’000 patients in Germany, Austria, Switzerland and the Czech Republic

    Healthcare
    • Investment date September 2024
    • Fund PAI Mid-Market Fund
    • Headquarters Austria
    • www.vamed.com/en/

  • Nutripure

    Nutripure is a holistic sport and wellness platform that allows consumers to take better care of their health

    Healthcare

  • Theramex

    Theramex is a leading global specialty pharmaceuticals company focused on women’s health.

    Healthcare
    • Investment date August 2022
    • Fund PAI Europe VII
    • Headquarters United Kingdom
    • www.theramex.com

  • Veonet

    Veonet is a leading pan-European ophthalmology clinics platform.

    Healthcare

  • Amplitude Surgical

    Leading French player on the global surgical technology market for lower-limb orthopaedics.

    Healthcare

  • Zahneins

    Zahneins is a leading German dental company.

    Healthcare
    • Investment date December 2019
    • Fund PAI Europe VII
    • Headquarters Germany
    • www.zahneins.com

  • ELITechGroup

    ELITechGroup is a global leader in specific niches of the in-vitro diagnostics market.

    Healthcare
    • Exit date May 2024
    • Investment date July 2017
    • Fund PAI Europe VI
    • Value at acquisition €355m
    • Headquarters Italy
    • www.elitechgroup.com

  • Atos Medical

    Atos Medical is the world leading provider of laryngectomy products.

    Healthcare
    • Exit date January 2022
    • Investment date July 2016
    • Fund PAI Europe VI
    • Value at acquisition SEK 7.7bn
    • Value at exit SEK 22.6bn
    • Headquarters Sweden
    • www.atosmedical.com

  • Ethypharm

    Ethypharm is a specialty pharmaceutical company active in the central nervous system and critical care areas with leading positions in pain and addiction treatments.

    Healthcare
    • Investment date July 2016
    • Fund PAI Europe VI
    • Value at acquisition €725m
    • Headquarters France
    • www.ethypharm.com

  • DomusVi

    DomusVi is a leading player in the European nursing home sector.

    Healthcare
    View case study
    • Exit date July 2017
    • Investment date September 2014
    • Fund PAI Europe VI
    • Value at acquisition €639m
    • Value at exit €2.4bn
    • Headquarters France
    • www.domusvi.com
More investments
Back to top